North America holds a 41.8% industry share. The U.S.-based industry captures a substantial revenue share, led by the rising penetration of healthcare facilities, and advanced medical technology.

The rising population in the U.S is expected to fuel the demand for hip and knee implants, denture base materials, and tooth implants, which will fuel the application of medical-grade polymers.

According to official data, around 55 million people are aged more than 65+ years, and it is predicted to cross 90 million in 2060.

The North American medical polymer industry is projected to rise due to growing demand for such plastics in pharmaceutical packaging applications, led by the expansion of the pharma industry in Canada.

In August 2021, Benvic Groups captured Chemres to become the worldwide major supplier of polymers, solutions, and custom compounds in various industries, such as packaging, medical, cables wires.

Germany is projected to experience the highest growth, at the rate 8.3% in the coming years. The nation is popular for technological advancements, more specifically in the healthcare sector. It has offered numerous opportunities for research institutes to invest in biodegradable and low-cost medical-grade polymers.

Fibers resins hold the largest industry share, of 72.5%, and it is ascribed due to the high electrical and chemical resistance, low weight, better biocompatiblity, and low cost of polyethylene, and polypropylene.

Therefore, the expansion of the pharmaceutical sector is projected to fuel the demand for medical polymer.